You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復鋭醫療科技(01696.HK)2021年溢利3250萬美元 同比增加121.5%
格隆匯 03-16 22:38

格隆匯3月16日丨復鋭醫療科技(01696.HK)公吿,截至2021年12月31日止年度的收益為2.94億美元,較去年的收益增加81.6%。年內溢利為3250萬美元,較去年的年內溢利增加121.5%。年度的經營活動所得現金流量淨額為3240萬美元,較去年增加25.8%。董事會議決就截至2021年12月31日止年度宣派末期股息每股股份0.157港元(含税)。

全部地區(主要在北美及亞太區)均錄得大幅增長。截至2021年12月31日止年度的北美洲所得收益為1.12億美元,較去年增加105.8%。截至2021年12月31日止年度的亞太區所得收益為8520萬美元,較去年增加95.3%。

復鋭醫療科技是全球美麗健康集團,深耕全球醫學美容行業已有二十多年,擅長運用能量源進行美容治療,以及解決醫療臨牀適應症。復鋭醫療向全球頂尖外科、醫療及美容診所提供產品與服務,用以守護世界各地成千上萬消費者的健康。

總收益增加主要歸因於COVID-19在2021年的不利影響相較2020年有所減退。於報吿期內收益有所增加的主要地區為北美洲(增加105.8%)、亞太區(增加95.3%)、拉丁美洲(增加76.3%)及歐洲(增加49.7%)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account